Extended reports
Differential contribution of HLA-DR, DQ, and TAP2 alleles to
systemic lupus erythematosus susceptibility in Spanish patients: role
of TAP2*01 alleles in Ro autoantibody production
a Departments of Immunology, b and Rheumatology, c Hospital Universitario "12 de Octubre",
Universidad Complutense, 28041 Madrid, Spain Department of
Immunology, Hospital Nta, Sra de Aránzazu, San Sebastián, Spain
Correspondence to: Dr A Arnaiz-Villena.
Accepted for publication 4 February 1998.
OBJECTIVE
To study the influence MHC class II and
TAP2 alleles exert on systemic lupus erythematosus (SLE) susceptibility
and on the clinical and serological manifestations of the disease, in a
cohort of Spanish patients.
METHODS
HLA-DR serological typing and HLA-DQA,
DQB, and TAP2 DNA sequence specific oligotyping, were carried out in 85 unrelated Spanish SLE patients and 186 healthy controls. Autoantibodies
detection was carried out by indirect immunofluorescence and counter immunoelectrophoresis.
RESULTS
Total SLE group: the frequency of HLA-DR3
and HLA-DQA1*0501 is significantly increased in this group
(pc<0.005,
=0.34 and pc<0.005,
= 0.45, respectively) although the highest
value (
=0.87) is obtained
when the TAP2*01 alleles are considered. No DQB allele shows
significant deviation from the control group. Renal damage: it mainly
occurs in HLA-DR3 patients (pc<0.0005 and
=0.72).
HLA-DQA1*0501 (pc<0.05,
=0.57) and DQB1*0201
(pc NS,
=0.56) are weaker susceptibility factors. Ro+
(but not La) group: this autoantibody response is associated with
TAP2*01 alleles in homozygosity (p<0.05,
=0.81). Ro/La+ group: it
has a different genetic background as HLA-DQA1*0501 (
=1) and
HLA-DQB1*0201 (
=1) are the main susceptibility factors.
CONCLUSIONS
A differential association between
HLA-DR, DQA1, and DQB1 alleles and SLE or its clinical and serological
manifestations are found. Furthermore, the associations are different
to the ones reported in other ethnic groups. Finally, TAP2*01 group of
alleles are associated with the highest susceptibility to SLE (higher than HLA-DR3) and may influence Ro (but not La) autoantibodies production, whereas HLA-DQA1*0501 and DQB1*0201 mediates concomitant Ro
and La production.
© 1998 by Annals of the Rheumatic Diseases
This article has been cited by other articles:
-
Ramal, L M, Lopez-Nevot, M A, Sabio, J M, Jaimez, L, Paco, L, Sanchez, J, de Ramon, E, Fernandez-Nebro, A, Ortego, N, Ruiz-Cantero, A, Rivera, F, Martin, J, Jimenez-Alonso, J, Grupo Lupus Virgen de las Nieves,
(2004). Systemic lupus erythematosus in southern Spain: a comparative clinical and genetic study between Caucasian and Gypsy patients. Lupus
13: 934-940
[Abstract] -
Kanagawa, S, Morinobu, A, Koshiba, M, Kageyama, G, Hayashi, N, Yoshino, S, Tokano, Y, Hashimoto, H, Kumagai, S
(2003). Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus. Lupus
12: 258-265
[Abstract] -
Correa, P A, Molina, J F, Pinto, L F, Arcos-Burgos, M, Herrera, M, Anaya, J-M
(2003). TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus. Ann Rheum Dis
62: 363-365
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
